These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 528399)

  • 1. Synthesis of isocoformycin, an adenosine deaminase inhibitor of synthetic origin.
    Shimazaki M; Kondo S; Maeda K; Ohno M; Umezawa H
    J Antibiot (Tokyo); 1979 May; 32(5):537-8. PubMed ID: 528399
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
    Shimazaki M; Kumada Y; Takeuchi T; Umezawa H; Watanabe K
    J Antibiot (Tokyo); 1979 Jun; 32(6):654-8. PubMed ID: 468739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.
    Hidaka T; Katayama K; Yamashita K; Yamashita T; Watanabe K; Shimazaki M; Ohno M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Mar; 33(3):303-9. PubMed ID: 7380742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the inhibition of adenosine deaminase.
    Montgomery JA; Thomas HJ; Zell AL; Einsphar HM; Bugg CE
    J Med Chem; 1985 Nov; 28(11):1751-3. PubMed ID: 4068002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenosine deaminase inhibitors. Synthesis and biological evaluation of (+/-)-3,6,7,8-tetrahydro-3-[(2-hydroxyethoxy)methyl]imidazo[4,5-d] [1,3]diazepin-8-ol and some selected C-5 homologues of pentostatin.
    Showalter HD; Putt SR; Borondy PE; Shillis JL
    J Med Chem; 1983 Oct; 26(10):1478-82. PubMed ID: 6604819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and hypoxic vasodilatation.
    Dóra E
    J Cereb Blood Flow Metab; 1985 Dec; 5(4):621-4. PubMed ID: 3877069
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
    Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of hypoxia on the guinea-pig myocardium following inhibition of adenosine deaminase by coformycin.
    Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):287-94. PubMed ID: 6476984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme inhibition titration assay for 2'-deoxycoformycin and its application to the study of the relationship between drug concentration and tissue adenosine deaminase in dogs and rats.
    Chassin MM; Adamson RH; Zaharevitz DW; Johns DG
    Biochem Pharmacol; 1979 Jun; 28(12):1849-55. PubMed ID: 454456
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
    Lum CT; Sutherland DE; Najarian JS
    Clin Immunol Immunopathol; 1979 Apr; 12(4):453-9. PubMed ID: 222523
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.
    Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):236-52. PubMed ID: 7103613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS; Koller CA; Kelley WN
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW
    Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract]   [Full Text] [Related]  

  • 17. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
    Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnotic effects of deoxycorformycin in rats.
    Radulovacki M; Virus RM; Djuricic-Nedelson M; Green RD
    Brain Res; 1983 Jul; 271(2):392-5. PubMed ID: 6604561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Biochem Pharmacol; 1982 Jun; 31(11):2103-9. PubMed ID: 6180754
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin.
    Kotb M; Veit BC
    Cell Immunol; 1982 Sep; 72(1):64-76. PubMed ID: 6983389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.